Texas Top Legal Officer Files Lawsuit Against Tylenol Producers Concerning Autism Spectrum Assertions

The top legal official in Texas Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the firms hid alleged dangers that the drug presented to pediatric cognitive development.

The lawsuit comes a month after President Donald Trump promoted an unproven link between taking acetaminophen - referred to as paracetamol - while pregnant and autism spectrum disorder in offspring.

The attorney general is filing suit against Johnson & Johnson, which previously sold the medication, the sole analgesic recommended for pregnant women, and the current manufacturer, which currently produces it.

In a official comment, he claimed they "misled consumers by making money from pain and marketing drugs ignoring the potential hazards."

The manufacturer asserts there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening countless individuals to line their pockets," Paxton, from the Republican party, stated.

Kenvue said in a statement that it was "deeply concerned by the spread of false claims on the security of paracetamol and the potential impact that could have on the welfare of women and children in America."

On its official site, Kenvue also stated it had "regularly reviewed the relevant science and there is no credible data that indicates a established connection between taking acetaminophen and autism."

Groups acting on behalf of physicians and health professionals share this view.

ACOG has stated paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to manage discomfort and elevated temperature, which can create serious health risks if not addressed.

"In more than two decades of investigation on the utilization of acetaminophen in gestation, zero credible investigations has definitively established that the consumption of acetaminophen in any stage of gestation causes neurological conditions in young ones," the group commented.

The lawsuit cites latest statements from the Trump administration in arguing the medication is potentially dangerous.

In recent weeks, the former president caused concern from medical authorities when he told women during pregnancy to "resist strongly" not to consume Tylenol when unwell.

The FDA then released a statement that doctors should contemplate reducing the use of acetaminophen, while also declaring that "a direct connection" between the drug and autism spectrum disorder in children has not been established.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had vowed in April to initiate "a massive testing and research effort" that would identify the source of autism in a limited time.

But specialists warned that identifying a single cause of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of inherited and external influences - would prove challenging.

Autism spectrum disorder is a category of permanent neurological difference and condition that affects how individuals experience and engage with the environment, and is recognized using physician assessments.

In his court filing, Paxton - who supports Trump who is running for the Senate - asserts Kenvue and J&J "deliberately disregarded and sought to suppress the research" around paracetamol and autism spectrum disorder.

This legal action aims to force the firms "destroy any commercial messaging" that asserts acetaminophen is safe for expectant mothers.

The Texas lawsuit echoes the complaints of a collection of guardians of children with autism and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in recently.

A federal judge rejected the case, stating studies from the parents' expert witnesses was inconclusive.